- Home
- BDTX vs WHF Comparison
BDTX vs WHF Comparison
Compare BDTX & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BDTX | WHF |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | 3 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 157.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | BDTX | WHF |
|---|---|---|
| Price | $2.09 | $7.07 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 6 | 2 |
| Target Price | ★ $10.20 | $7.75 |
| AVG Volume (30 Days) | ★ 592.3K | 130.8K |
| Earning Date | 03-16-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 14.16% |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $5.53 | $15.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.20 | $6.07 |
| 52 Week High | $4.94 | $9.95 |
Technical Indicators
Market Signals| Indicator | BDTX | WHF |
|---|---|---|
| Relative Strength Index (RSI) | 39.51 | 54.52 |
| Support Level | $1.93 | $6.87 |
| Resistance Level | $2.86 | $7.24 |
| Average True Range (ATR) | 0.14 | 0.22 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 24.11 | 56.05 |
Price Performance
Historical ComparisonAbout BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.